The good news is that the Obama Administration told Congress that it was committed to drug safety. The bad news is that Budget Director Peter Orszag delivered the news. After going without a Commissioner for half of the Bush Administration, FDA is still without a nominee for commissioner by President Obama.
An interesting article by Reuters is posted on the right under (oddly enough) “Interesting Articles” (Drug Safety…). I’m happy that Congress is concerned about drug safety for imported drugs. I am very unhappy that they aren’t discussing the issue at the same time they are confirming a new Food & Drug Commissioner. FDA needs new leadership committed to public health. Immediately.
Top choices are: Joshua Sharfstein, Baltimore Health Commissioner; Steve Nissen from the Cleveland Clinic, and Center for Drugs mainstay Janet Woodcock. My vote is for new blood (read Sharfstein or Nissen). However, and you need to trust me on this, my opinion counts for very little east of Fife, WA (the state, not the city).